The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis
2011

Understanding the SOX2 Response Program in Glioblastoma

Sample size: 3 publication Evidence: high

Author Information

Author(s): Fang Xuefeng, Yoon Jae-Geun, Li Lisha, Yu Wei, Shao Jiaofang, Hua Dasong, Zheng Shu, Hood Leroy, Goodlett David R, Foltz Gregory, Lin Biaoyang

Primary Institution: Swedish Neuroscience Institute, Swedish Medical Center, Seattle, WA, USA

Hypothesis

The re-activation program of SOX2 may play an important role in the carcinogenesis and maintenance of glioblastoma multiforme (GBM).

Conclusion

The study provides insights into the SOX2 response program in GBM, highlighting its potential role in cancer development.

Supporting Evidence

  • Knockdown of SOX2 in LN229 cells significantly reduced colony formation.
  • SOX2 binding regions were identified in the GBM cancer genome using ChIP-seq technology.
  • Microarray analysis identified 489 genes whose expression altered in response to SOX2 knockdown.
  • SOX2 regulates the expression of SOX family proteins SOX1 and SOX18.
  • SOX2 down regulates BEX1 and BEX2, two genes with tumor suppressor activity in GBM.
  • miR-145 and SOX2 form a double negative feedback loop in GBM cells.

Takeaway

Scientists studied a gene called SOX2 in brain cancer cells to see how it helps the cancer grow. They found that when they turned off SOX2, the cancer cells didn't grow as much.

Methodology

The study used ChIP-seq, microarray profiling, and microRNA sequencing to analyze the effects of SOX2 knockdown in LN229 GBM cells.

Statistical Information

P-Value

0.00015

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2164-12-11

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication